Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides
Article first published online: 26 JUN 2009
DOI: 10.1111/j.1600-0560.2009.01264.x
Copyright © 2009 John Wiley & Sons A/S
Additional Information
How to Cite
Ioannou, M., Sourli, F., Mylonis, I., Barbanis, S., Papamichali, R., Kouvaras, E., Zafiriou, E., Siomou, P., Klimi, E., Simos, G., Roussaki-Schulze, A.-V. and Koukoulis, G. (2009), Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides. Journal of Cutaneous Pathology, 36: 1255–1261. doi: 10.1111/j.1600-0560.2009.01264.x
Publication History
- Issue published online: 26 OCT 2009
- Article first published online: 26 JUN 2009
- Accepted for publication January 16, 2009
- Abstract
- Article
- References
- Cited By
Background: Expression of hypoxia inducible factor 1 (HIF-1) alpha can be linked to inflammation through reciprocal interactions with several cytokines. This finding is in accordance with the previously noted HIF-1 alpha overexpression in psoriatic lesional keratinocytes.
Methods: In this study we have employed a carefully selected panel of antibodies and quantitative morphometric analysis to compare HIF-1 alpha immunoreactivity in psoriatic biopsy samples vs. that in samples obtained from psoriasiform dermatitides.
Results: We found statistically significant HIF-1 alpha overexpression in psoriasis. Furthermore, we observed a previously unreported preferential localization of immunoreactive keratinocytes in the immediate vicinity of inflamed and elongated papillae. This pattern of immunoreactivity may partially account for the observed increase of HIF-1 alpha immunostaining in psoriasis.
Conclusions: Overall, our findings imply that possible novel therapeutic intervention(s) on the HIF-1 alpha pathway may offer another approach in controlling the inflammatory activity of psoriatic lesions.

1600-0560/asset/olbannerleft.jpg?v=1&s=f550524ae971b4a0a06c3ec1d56b1833b462eb2d)
1600-0560/asset/olbannerright.jpg?v=1&s=3a96f574dc4e1bfda47da3c1728fe6b395cc334d)
